2024 Volume 38 Issue 1 Pages 117-122
It is important to efficiently understand clinical symptoms and promote appropriate treatment within the limited consultation time. In the case of atopic dermatitis, severity evaluation methods such as SCORAD and EASI are used to determine the effectiveness of treatment. In the case of bronchial asthma, we conduct a questionnaire that allows us to easily and objectively evaluate the control status over the past month during daily medical treatment, and evaluate respiratory function using a spirometer and peak flow. However, there are few evaluation charts that pediatricians can easily use for allergic rhinitis and allergic conjunctivitis. Sublingual immunotherapy for cedar hay fever and treatments for perennial mite allergic rhinitis are also being used in children, and the challenge is how to evaluate their therapeutic effects. Symptom severity (total nasal symptom score: TNSS), score considering drug therapy (total nasal symptom/medication score), and QOL questionnaire introduced in the Nasal Allergy Treatment Guidelines 2020 Edition (PG-MARJ2020) are also included. To assess the risk of allergies in children, we used the Japanese Rhinoconjunctivitis Quality of Life Questionnaire (JRQLQ), the International Guidelines for Allergic Rhinitis and Its Impact on Asthma (ARIA), and the Visual Analogue Scale (VAS) of the Facial Scale. Introducing research using. Let's think about what kind of evaluation chart is needed to treat rhinitis and hay fever.